Prevention of cyclic and triton-induced increases in hydroxymethylglutaryl coenzyme A reductase and sterol synthesis by puromycin.
D000085:Acetates / Q000378:metabolism; D000429:Alcohol Oxidoreductases / Q000378:metabolism*; D000818:Animals; D002247:Carbon Isotopes; D002849:Chromatography, Gas; D002940:Circadian Rhythm / Q000187:drug effects; D003065:Coenzyme A; D003609:Dactinomycin / Q000494:pharmacology; D003864:Depression, Chemical; D005227:Fatty Acids / Q000096:biosynthesis; D005977:Glutarates; D006863:Hydrogen-Ion Concentration; D066298:In Vitro Techniques; D008099:Liver / Q000201:enzymology* / Q000378:metabolism; D008297:Male; D008722:Methods; D008798:Mevalonic Acid / Q000096:biosynthesis; D051379:Mice; D008861:Microsomes / Q000201:enzymology*; D009249:NADP / Q000494:pharmacology; D011691:Puromycin / Q000494:pharmacology*; D013261:Sterols / Q000096:biosynthesis*; D013268:Stimulation, Chemical; D013501:Surface-Active Agents / Q000494:pharmacology*
D000085:Acetates; D002247:Carbon Isotopes; D005227:Fatty Acids; D005977:Glutarates; D013261:Sterols; D013501:Surface-Active Agents; D003609:Dactinomycin; D011691:Puromycin; D009249:NADP; D000429:Alcohol Oxidoreductases; D008798:Mevalonic Acid; D003065:Coenzyme A